Company & Sponsor Intelligence

All India Institute of Medical Sciences

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials5

Recruiting1

Completed1

Countries1

Therapeutic footprint

autismepilepsymigraine_headache

Indexed studies

NCT06315465Efficacy of MAD as add-on Therapy in Comparison With Standard of Care in Children With ASD
autism · PHASE2, PHASE3

NCT02708030Dietary Therapy In Epilepsy Treatment (DIET-Trial): A Randomised Non Inferiority Trial Comparing KD, MAD & LGIT for Drug Resistant Epilepsy
epilepsy · IndiaNA

NCT03464487Comparison Between Efficacy of Daily and Intermittent Low Glycemic Index Therapy Diet
epilepsy · IndiaNA

NCT07797725Efficacy of Low Glycemic Index Diet vs Modified Atkins Diet and Gluten Free Casein Free Diet as add-on Therapy With Standard of Care in Children With Autism Spectrum Disorder
autism · IndiaNA

NCT04984720Efficacy of Smartphone Based Digital Application in Improving Headache Related Parameters in Patients With Migraine
migraine_headache · IndiaNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →